The global VCD market will grow modestly through 2027 as a result of increasing endovascular interventional procedural volumes, and increasing clinical data that demonstrates the financial and outcomes benefits associated with VCD use.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the global market for VCDs across a 10-year period.


The global VCD market is driven by procedural trends in many endovascular market segments.

Which procedures are expected to grow through 2027?

How can competitors in the VCD space leverage procedural trends to grow their revenues in the VCD market?

The pace of change towards radial access has been different between some countries.

How have guidelines adapted to the increasing volume of clinical data showing the benefits of radial access?

In which countries are physicians more likely to adopt a radial approach towards their endovascular procedures?

How will the shift to radial access affect the global VCD market?

A significant number of novel VCDs have been launched or are in development across the global market.

What are some areas of focus for innovators in the VCD space?

How have manufacturers differentiated their VCDs from competitors upon launch?

How have recently launched large-bore closure devices products performed in the global market?

What are some synergies that exist between VCDs and other products?

Table of contents

  • Global
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Minimally Invasive Cardiovascular Procedure Analysis
      • Procedure Highlights
      • Procedure Definitions
      • Procedure Forecast Data
        • By Indication
        • By Size
        • By Procedure Type
        • By Access Site
        • By Technique
        • By Region
    • Vascular Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Mergers, Acquisitions, and Partnerships
        • Pricing Strategies and Purchasing Options
        • Product Improvements and Innovations
        • Product Portfolio Management
        • Local Marketing Strategies
        • Regulatory Environment
      • Market Developments
    • Invasive Vascular Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Market Shares
    • Hemostatic Patch Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Market Shares
    • Assisted Manual Compression Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Market Shares
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Michael Tian, PhD

Michael Tian is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resources Group and is an expert in interventional cardiology, cardiac surgery, vascular access, and interventional oncology device markets. Michael spends much of his time exploring and translating large claims and hospital purchase datasets into intriguing stories within the global MedTech market, and he is always looking for the next challenging question to tackle. Michael holds a in Physiology and Neuroscience from the University of Toronto.


Related Reports

Aortic Repair Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for aortic repair devices will expand at a moderate rate through 2027, driven primarily by endovascular procedure volume growth and the continued developme...

View Details

Electrophysiology Mapping and Ablation Devices | Medtech 360 | Market Insights | Japan

The Japan EP mapping and ablation device market will experience moderate growth through 2027, due to favorable reimburseme...

View Details

Structural Heart Closure Devices | Medtech 360 | Market Insights | Global

The global market for structural heart closure devices will grow rapidly in most countries covered through 2028, driven by strong clinical data, the availability of reimbursement, a...

View Details

Transcatheter Embolization and Occlusion Devices | Medtech 360 | Market Insights | Japan

Japan's aging population will drive steady growth in TEO procedure volumes through 2028, supporting TEO device market expansion, although revenue growth will continue to be hindered by...

View Details